We are live on
!
Find out more
NC
Northpointe Capital Portfolio holdings
AUM
$258M
1-Year Est. Return
1.97%
This Fund
S&P 500
This Quarter
Est. Return
+11.69%
1 Year Est. Return
-1.97%
3 Year Est. Return
+33.01%
5 Year Est. Return
+82.13%
10 Year Est. Return
–
AUM
$867M
AUM Growth
–
Cap. Flow
+$826M
Cap. Flow
% of AUM
95.31%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
231
New
231
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CBK
Christopher & Banks Corporation
CBK
|
+$22.8M |
| 2 |
MRGE
MERGE HEALTHCARE INC COM STK (WI)
MRGE
|
+$18.8M |
| 3 |
Repligen
RGEN
|
+$18.6M |
| 4 |
VRNT
Verint Systems
VRNT
|
+$18.6M |
| 5 |
Acadia Healthcare
ACHC
|
+$18M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Industrials | 18.23% |
| 2 | Technology | 14.54% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Healthcare | 12.26% |
| 5 | Financials | 7.26% |
Similar funds
GWA
KCM
WIM
LCM
IVGAI
BW
IPC
AEPG
Northpointe Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Northpointe Capital, which disclosed 231 positions worth $867M. Its ten largest holdings account for 22% of the portfolio.
Its largest position is Christopher & Banks Corporation: 3,376,457 shares worth $22.8M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, followed by Technology and Consumer Discretionary.
- Northpointe Capital's largest Q2 2013 buy was Christopher & Banks Corporation: 3,376,457 shares worth $22.8M.
- Northpointe Capital's ten largest holdings make up 22% of its $867M portfolio in Q2 2013.
- Northpointe Capital disclosed 231 positions in Q2 2013, its first 13F filing on record.
Based on Northpointe Capital's 13F filing for Q2 2013, filed 9 Aug 2013.